{"id":3638,"date":"2018-01-12T09:12:49","date_gmt":"2018-01-12T14:12:49","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=3638"},"modified":"2018-01-12T09:12:49","modified_gmt":"2018-01-12T14:12:49","slug":"ipo-pipeline-update-week-ending-1-12-18","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-pipeline-update-week-ending-1-12-18\/","title":{"rendered":"IPO Pipeline Update ( Week ending 1.12.18)"},"content":{"rendered":"


\n<\/a>IPO Boutique keeps apprised of the active pipeline. Currently there are 65 active IPOs in the pipeline as of January 12, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article.<\/strong><\/a><\/p>\n

\"Screen<\/a><\/p>\n

NEW FILINGS<\/strong><\/p>\n

\"MotusGi\"<\/a><\/p>\n

Company: Motus GI Holdings, Inc.<\/strong>
\nSymbol: MOTS
\nDescription: They have developed a single-use medical device system cleared by the United States Food and Drug Administration, that is intended to connect to standard colonoscopes to help facilitate intraprocedural cleaning of a poorly prepared colon by irrigating or cleaning the colon and evacuating the irrigation fluid, feces and other bodily fluids and matter.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Piper Jaffray, Oppenheimer & Co.
\nFiled: 1-5-17
\nListed: Cash Raise: $28.75m<\/p>\n

\"bioceressa\"<\/a>Company: Bioceres S.A.<\/strong>
\nSymbol: BIOX
\nDescription: They are a fully-integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants and fertilizers.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Jefferies, Piper Jaffray, Santander
\nCo-Manager: Mirabaud Securities
\nFiled: 1-8-17
\nListed: Cash Raise: $100m<\/p>\n

\"Evolusinc\"<\/a>Company: Evolus, Inc.<\/strong>
\nSymbol: EOLS
\nDescription: They are a medical aesthetics company focused on providing physicians and their patients with expanded choices in aesthetic procedures and treatments.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Cantor, Mizuho Securities
\nCo-Manager: SunTrust Robinson Humphrey, JMP Securities
\nFiled: 1-9-17
\nListed: Cash Raise: $75m<\/p>\n

\"VictoryCapital\"<\/a>Company: Victory Capital Holdings, Inc.<\/strong>
\nSymbol: VCTR
\nDescription: They are an independent investment management firm operating a next generation, integrated multi-boutique model with $59.0 billion in assets under management, or AUM, as of September 30, 2017.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): J.P. Morgan, BofA Merrill Lynch, Morgan Stanley, Barclays, Goldman Sachs & Co., RBC Capital Markets
\nCo-Manager: Keefe Bruyette & Woods, William Blair
\nFiled: 1-11-17
\nListed: Cash Raise: $100m<\/p>\n

UPDATED TERMS<\/strong><\/span><\/p>\n

\"nine-logo-blue\"<\/a>Company: Nine Energy Service, Inc.<\/strong>
\nSymbol: NINE
\nShares: 7 million
\nPrice: $20.00-$23.00
\nDescription: They are a leading North American onshore completion and production services provider that targets unconventional oil and gas resource development. We partner with our exploration and production customers across all major onshore basins in both the U.S. and Canada to design and deploy downhole solutions and technology to prepare horizontal, multistage wells for production.
\nTrade Date: 1\/19
\nUnderwriter(s): J.P. Morgan, Goldman Sachs & Co., Wells Fargo, BofA Merrill Lynch, Credit Suisse
\nCo-Manager(s): Raymond James, Simmons & Company International, Tudor Pickering Holt & Co., HSBC, Scotia Howard Weil, UBS Investment Bank
\nTerms Added: 1-9-18<\/p>\n

\"americoldrealty\"<\/a>Company: Americold Realty Trust<\/strong>
\nSymbol: COLD
\nDescription: They are the world\u2019s largest owner and operator of temperature-controlled warehouses.
\nShares: 24 million
\nPrice Range: $14.00-$16.00
\nTrade Date: 1\/19
\nUnderwriter(s): BofA Merrill Lynch, J.P. Morgan, RBC Capital
\nCo-Manager(s): Rabo Securities, Baird, Citizens Capital Markets, Raymond James, SunTrust Robinson Humphrey, BB&T Capital Markets, BTIG
\nFiled: 1-9-18<\/p>\n

\"eyenovia\"<\/a>Company: Eyenovia, Inc.<\/strong>
\nSymbol: EYEN
\nDescription: They are a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing our patented piezo-print technology to deliver micro-doses of active pharmaceutical ingredients, or micro-therapeutics, topically to the eye.
\nShares: 2.73 million
\nPrice Range: $10.00-$12.00
\nTrade Date: TBD
\nUnderwriter(s): Ladenburg Thalmann, Roth Capital Partners
\nTerms Added: 1-9-18<\/p>\n

\"pagseguro\"<\/a>Company: PagSeguro Digital Ltd.<\/strong>
\nSymbol: PAGS
\nDescription: They are a disruptive provider of financial technology solutions focused primarily on Micro-Merchants, Small Companies and Medium-Sized Companies, or SMEs, in Brazil.
\nShares: 92.1 million
\nPrice Range: $17.50-$20.50
\nTrade Date: 1\/25
\nUnderwriter(s): Goldman Sachs & Co., Morgan Stanley, BofA Merrill Lynch, Credit Suisse, Deutsche Bank Securities, J.P. Morgan
\nTerms Added: 1-10-18<\/p>\n

\"GatesIndustrialCorp\"<\/a>
\n<\/a>Company: Gates Industrial Corporation plc<\/strong>
\nSymbol: GTES
\nDescription: They are a global manufacturer of innovative, highly engineered power transmission and fluid power solutions.
\nShares: 38.5 million
\nPrice Range: $18.00-$21.00
\nTrade Date: 1\/25
\nUnderwriter(s): Citigroup, Morgan Stanley, UBS Investment Bank, Barclays, Credit Suisse, Goldman Sachs & Co., RBC Capital Markets
\nCo-Manager(s): Blackstone Capital Markets, Deutsche Bank Securities, Wells Fargo Securities, Current Capital Securities, KeyBanc Capital Markets, Siebert Cisneros Shank & Co., SunTrust Robinson Humphrey, Academy Securities, BTIG, Guggenheim Securities
\nTerms Added: 1-12-18<\/p>\n

\"MenloTherapeutics\"Company: Menlo Therapeutics, Inc.
\nSymbol: MNLO
\nDescription: They are a late\u2011stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis.
\nShares: 5.67 million
\nPrice Range: $14.00-$16.00
\nTrade Date: 1\/25
\nUnderwriter(s): Jefferies, Piper Jaffray, Guggenheim Securities
\nCo-Manager(s): JMP Securities
\nTerms Added: 1-12-18<\/p>\n","protected":false},"excerpt":{"rendered":"

IPO Boutique keeps apprised of the active pipeline. Currently there are 65 active IPOs in the pipeline as of January 12, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article. NEW FILINGS Company: Motus[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[],"class_list":["post-3638","post","type-post","status-publish","format-standard","hentry","category-ipo"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3638","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=3638"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3638\/revisions"}],"predecessor-version":[{"id":3651,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3638\/revisions\/3651"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=3638"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=3638"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=3638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}